PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-09-25

Date Title Company
25-Sep-2024 Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of Insomnia Nxera Pharma
25-Sep-2024 Santhera Announces Acceptance by Swissmedic of Marketing Authorization Application for AGAMREE® (vamorolone) in Duchenne Muscular Dystrophy Santhera Pharmaceuticals
25-Sep-2024 Quasar Medical Acquires Ridgeback Technologies AccessWire
25-Sep-2024 SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders AccessWire
25-Sep-2024 Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands AccessWire
25-Sep-2024 Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US Newswire
25-Sep-2024 Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US AccessWire
25-Sep-2024 GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis AccessWire
25-Sep-2024 Incredable(TM) (Formerly Ready Doc(R)) Launches New Provider App and Announces Attendance at NAMMS Conference AccessWire
25-Sep-2024 GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis Newswire
25-Sep-2024 Africa CDC and IAVI Sign Memorandum of Understanding to Enhance Vaccine and Antibody Research Capacity in Africa AccessWire
25-Sep-2024 Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 AccessWire
25-Sep-2024 Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA AccessWire
25-Sep-2024 NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split AccessWire
25-Sep-2024 Explosive Growth in 3D Imaging Market Driven by Advancements in Healthcare and Industrial Applications Acumen Research And Consulting
25-Sep-2024 Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call Newswire
25-Sep-2024 Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call AccessWire
25-Sep-2024 Employee Upskilling Not a Priority for One-in-Seven UK Manufacturers Visual Components
25-Sep-2024 Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9%, or 28.1% at constant currency in 1H 2024. Medacta Group SA
25-Sep-2024 Creative Enzymes Unveils Innovative Bacteriophage Solutions to Combat Antibiotic Resistance Creative Enzymes